loader2
Login Open ICICI 3-in-1 Account

Entry Price

2,027.00

Target

2,400.00

Recommend Date

11-08-2020

Return

18.40 %
BUY

Date : 11-08-2020

Revenues grew 42.3% YoY to | 1534.4 crore (I-direct estimate: | 1287.8 crore) due to one-time opportunity of ~| 259 crore for HCQS/chloroquine supplies in both API & formulation segments. Export formulations grew 89.4% YoY to | 463.6 crore and API segment grew 72.0% YoY to | 513.3 crore. Domestic revenues grew 8.1% YoY to | 489.4 crore. EBITDA margins improved to 38.3% vs. 18.3% in Q1FY20 (I-direct estimate: 20.0%) due to lower operational expenditure. EBITDA grew 198.4% YoY to | 588.3 crore (I-direct estimate: | 257.6 crore). PAT grew 244% YoY to | 445.9 crore (Idirect estimate: | 180 crore) mainly due to a strong operational performance and lower tax rate (18.3% against 22.4% in Q1FY20).